Table 2 Univariate logistic regressions comparing subtypes or clinicopathological features across subtypes.

From: Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status

 

SN−

SN+

OR

95% CI

p value

Subtype

     

NormL

232

107

Ref

 

0.001

LumA

370

227

1.33

[1.00;1.76]

 

LumB

143

87

1.32

[0.93;1.87]

 

LumC

92

57

1.34

[0.90;2.01]

 

BasL

134

36

0.58

[0.38;0.90]

 

mApo

49

22

0.97

[0.56;1.69]

 

Menopause

     

Premenopause

246

149

Ref

 

0.11

Postmenopause

774

387

0.83

[0.65;1.05]

 

Tumor size

     

11–20 mm

699

261

Ref

 

 < 0.0001

> 20 mm

321

275

2.29

[1.85;2.84]

 

Grade

     

1

273

133

Ref

 

0.12

2

438

267

1.25

[0.56;1.69]

 

3

260

127

1.00

[0.75;1.35]

 

N/A

49

9

-

-

-

Subtype (ERBB2)

     

NormL + LumA + B

745

421

Ref

 

0.96

mApo + LumC

141

79

1.01

[0.75;1.36]

 
  1. The odds ratio (OR) and 95% confidence interval (CI) for SN + vs. SN − is presented for each group compared to a reference (Ref). p values represent those of the χ2 test across all categories excluding unknowns.